Maki Hagihara
Overview
Explore the profile of Maki Hagihara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishii Y, Fujisawa S, Miyazaki T, Nakajima Y, Matsumura A, Fujimaki K, et al.
Int J Hematol
. 2024 Nov;
121(2):187-193.
PMID: 39560911
Although tyrosine kinase inhibitors (TKIs) have improved the prognosis of chronic myeloid leukemia (CML), some patients do not respond to TKIs. We evaluated 21 patients with CML treated with asciminib,...
2.
Nukui J, Tachibana T, Miyazaki T, Tanaka M, Matsumoto K, Ishii Y, et al.
Hematology
. 2024 Nov;
29(1):2424053.
PMID: 39495151
Objectives: Our previous study showed that a high pre-transplant nucleated cell count in the bone marrow is associated with increased non-relapse mortality (NRM) and decreased overall survival (OS) in patients...
3.
Shimizu H, Kato J, Tanoue S, Kimura S, Tachibana T, Hatano K, et al.
Leuk Res
. 2024 Aug;
144:107562.
PMID: 39178610
To investigate the safety of total body irradiation-based myeloablative conditioning (TBI-MAC) in adolescent and young adult (AYA) Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (ALL) patients treated with pediatric protocols, treatment...
4.
Miyazaki T, Kamimura D, Wakamatsu M, Konishi M, Matsumura A, Teshigawara H, et al.
J Clin Exp Hematop
. 2024 Jul;
64(3):232-236.
PMID: 39085132
Erdheim-Chester disease (ECD) is a rare, non-Langerhans cell histiocytosis with diverse clinical features. It is characterized by systemic histiocyte infiltration of the bone, skin, central nervous system, lung, kidney, and...
5.
Ohwada C, Sakaida E, Takeda Y, Doki N, Igarashi A, Onizuka M, et al.
Int J Hematol
. 2024 Jul;
120(3):347-355.
PMID: 39017858
A prospective multicenter observational study of organ response was conducted in patients with chronic GVHD diagnosed by the NIH criteria. When response was assessed at 12 months (12 M) in...
6.
Tachibana T, Miyazaki T, Matsumura A, Hagihara M, Tanaka M, Koyama S, et al.
Cytotherapy
. 2024 Apr;
26(8):921-929.
PMID: 38625069
Background: Various biomarkers have been developed and evaluated to predict the prognosis and complications of allogeneic hematopoietic cell transplantation (HCT). Most previous studies conducted on different biomarkers evaluated single effects...
7.
Ohashi T, Kunimoto H, Nukui J, Teshigawara H, Koyama S, Miyazaki T, et al.
Int J Hematol
. 2024 Mar;
119(5):603-607.
PMID: 38489090
Bloom syndrome (BS) is an autosomal recessive genetic disorder caused by variants in the BLM gene. BS is characterized by distinct facial features, elongated limbs, and various dermatological complications including...
8.
Yanagisawa R, Shindo M, Shinohara A, Kuwatsuka Y, Nakase K, Kimura F, et al.
Transplant Proc
. 2024 Feb;
56(2):416-421.
PMID: 38336483
Background: As the Japanese population may have less genetic diversity than other ethnic groups, treatment outcomes may be affected when allogeneic hematopoietic cell transplantation is performed in other races. However,...
9.
Nukui J, Tachibana T, Miyazaki T, Tanaka M, Matsumoto K, Ishii Y, et al.
Int J Hematol
. 2023 Dec;
119(1):62-70.
PMID: 38082200
The clinical implications of recipient bone marrow nucleated cell count (NCC) prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT) remain unknown. We conducted a multicenter retrospective study to evaluate the...
10.
Sakuma T, Fujisawa S, Tanaka M, Hagihara M, Fujita H, Fujimaki K, et al.
Hematol Oncol
. 2023 Sep;
42(1):e3228.
PMID: 37731313
The CFA ratio, calculated using pretreatment C-reactive protein (CRP), fibrinogen, and albumin levels (CRP × fibrinogen/albumin), was previously reported to be a significant prognostic factor for acute myeloid leukemia (AML)....